The transplant diagnostics market has witnessed rapid growth, increasing from $1.82 billion in 2023 to $2.01 billion in 2024, with a compound annual growth rate (CAGR) of 10.7%. This growth is driven by advancements in HLA typing, the increasing number of organ transplantations, improvements in immunosuppressive therapy, cross-matching techniques, and regulatory standardization. The market is projected to reach $2.57 billion by 2028, reflecting a CAGR of 6.3%. Future growth is supported by patient-centric approaches, regulatory adaptations, the rise in living donor transplants, personalized transplant medicine, and the growth in transplant procedures. Major trends include education and awareness programs, market expansion strategies, evolving regulatory guidelines, optimization of immunosuppressive therapy, and the development of biomarkers.
Major Driver In The Transplant Diagnostics Market
The transplant diagnostics market is witnessing growth driven by the rising incidence of acute diseases leading to increased organ failure rates and subsequently higher demand for transplant procedures. Organ transplant procedures, which are complex and reliant on the successful acceptance of the donor's organ by the recipient's body system, require diagnostic tests to determine feasibility. According to the United Network for Organ Sharing, the U.S. recorded a record-setting number of organ transplants in 2021, including 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplantation procedures. This surge in demand for diagnostic tests is a key factor driving the transplant diagnostics market, evident in 2023 and expected to continue through 2024 and 2028.
Request A Free Sample Of The Global Transplant Diagnostics Market Report
Transplant Diagnostics Market Competitive Landscape
F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomérieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive plc, BioGenuix, Pure Transplant Solutions
Key Transplant Diagnostics Market Trend
Major companies operating in the transplant diagnostics market are focused on introducing advanced transplant diagnostics services to maximize their profits in the market. Advanced transplant diagnostic services refer to the use of novel and advanced diagnostic tools and technologies to improve the accuracy and efficiency of pre-transplant and post-transplant testing. For instance, in March 2023, Quest Diagnostics, a US-based medical laboratory company, launched Quest Advanced Specialized Transplant Services, an extensive collection of innovative diagnostics and support services created to increase access to lab tests for solid organ, human cell, and tissue transplants. It features a thorough selection of more than 170 specialized transplant and infectious disease tests, longitudinal trend analysis of test results in the doctor's electronic medical record (EMR), and round-the-clock support services, including medical consultation to ensure appropriate test selection and result interpretation affecting care. The new services build on Quest's previous offering in transplant testing with new capabilities. These capabilities include new patient-customized information packets to help educate patients on the process and help Quest's phlebotomists fast-track testing for patients visiting one of Quest's 2,100 patient service centers. Results for some tests can be obtained within 8–24 hours.
Get The Full Global Transplant Diagnostics Market Report
Transplant Diagnostics Market Segmentation
The transplant diagnostics market covered in this report is segmented –
1) By Type: Reagent & Consumables, Instrument, Software & Services
2) By Transplant Type: Solid Organ, Stem Cell
3) By Organ: Kidney, Liver, Heart, Lung, Pancreas
4) By Technology: Non Molecular Assay, Molecular Assay
5) By End User: Hospitals and Transplant Centers, Research Laboratories & Transplant Centers, Commercial Service Providers
By Geography:The regions covered in the transplant diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
North America was the largest region in the transplant diagnostics market in 2023.
The Transplant Diagnostics Global Market Report 2024 furnishes information about the global transplant diagnostics market, encompassing details like market size, projections for growth, segmentation across various sectors and regions, and an overview of competitors, including their revenues, profiles, and market shares. Furthermore, the report pinpoints potential opportunities and strategic directions derived from market trends and the strategies adopted by key competitors. The report also offers an assessment of how the COVID-19 pandemic, the Russia-Ukraine conflict, and increasing inflation have affected both global and regional markets, furnishing valuable strategic insights for businesses.
